- cafead Jun 18, 2024 at 08:12: PM
via Boston Scientific's road to transcarotid artery revascularization (TCAR) has been paved by Silk Road Medical – in the form of a $1.16 billion acquisition.
Silk Road Medical has long been considered one of the 25 Most Attractive Medtech M&A Targets for its innovative platform of products designed to prevent stroke in patients with carotid artery disease through the TCAR procedure.
article source
Silk Road Medical has long been considered one of the 25 Most Attractive Medtech M&A Targets for its innovative platform of products designed to prevent stroke in patients with carotid artery disease through the TCAR procedure.
article source